Medical Chronicle November/December 2013 | Page 55

U N T R E AT E D

WEEK 4

WEEK 8

WEEK 12

4-n-Butylresorcinol ? a highly effective
tyrosinase inhibitor.
Now in EUCERIN® EVEN BRIGHTER

NEW

EUCERIN® Skin Research offers an effective and safe solution for
the topical treatment of hyperpigmentation. With highly effective
B-Resorcinol, clinically shown to be a superior human tyrosinase
inhibitor*, NEW EUCERIN® EVEN BRIGHTER works deeper to
reduce hyperpigmentation at the source.
Tolerability and efficacy are clinically proven, with the first visible
effects evident after just 4 weeks of use, and increasing over time.
(B-Resorcinol is a synthetic organic compound, which is chemically different from resorcinol)

www.eucerin.com

*Topical treatment of hyperpigmentation. L Kolbe, T Mann,
W Gerwat, J Batzer, S Ahlheit, C Scherner, H Wenck, F Stab

MEDICAL SKIN SCIENCE THAT SHOWS